What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Michael I. D’Angelica mainly focuses on Surgery, Internal medicine, Hepatectomy, Retrospective cohort study and Colorectal cancer.
His Surgery research incorporates themes from Cancer and Pancreas.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Oncology.
His Hepatectomy research includes themes of Gallbladder cancer, Urology, Rectum, Case-control study and Survival analysis.
His Retrospective cohort study research is multidisciplinary, incorporating elements of Young adult, Radiology, Cohort study and General surgery.
The study incorporates disciplines such as Primary tumor and Proportional hazards model in addition to Colorectal cancer.
His most cited work include:
- The international position on laparoscopic liver surgery: The Louisville Statement, 2008. (1050 citations)
- Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure (801 citations)
- CD133 expression is not restricted to stem cells, and both CD133 + and CD133 – metastatic colon cancer cells initiate tumors (787 citations)
What are the main themes of his work throughout his whole career to date?
Michael I. D’Angelica focuses on Surgery, Internal medicine, Colorectal cancer, Hepatectomy and Gastroenterology.
His Surgery study incorporates themes from Metastasis and Radiology.
His research investigates the connection between Internal medicine and topics such as Oncology that intersect with problems in KRAS.
Michael I. D’Angelica combines subjects such as Survival rate, Prospective cohort study and Disease with his study of Colorectal cancer.
His Hepatectomy research is multidisciplinary, relying on both Primary tumor and Survival analysis.
His work on Intrahepatic Cholangiocarcinoma as part of his general Gastroenterology study is frequently connected to In patient, thereby bridging the divide between different branches of science.
He most often published in these fields:
- Surgery (44.78%)
- Internal medicine (38.38%)
- Colorectal cancer (24.95%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (38.38%)
- Chemotherapy (17.70%)
- Gastroenterology (20.68%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Chemotherapy, Gastroenterology, Surgery and Surgical oncology.
His work in the fields of Colorectal cancer, Hazard ratio and KRAS overlaps with other areas such as In patient.
His work deals with themes such as Artery, Artery infusion, Adjuvant and Metastasis, Hepatic arterial infusion, which intersect with Chemotherapy.
His Gastroenterology research is multidisciplinary, incorporating perspectives in Cancer, CDKN2A, Exact test and Cumulative incidence.
Michael I. D’Angelica regularly links together related areas like Infusion pump in his Surgery studies.
His research integrates issues of Logistic regression, Complication, Retrospective cohort study and Prognostic variable in his study of Hepatectomy.
Between 2019 and 2021, his most popular works were:
- Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients. (37 citations)
- Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial. (24 citations)
- Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer. (20 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His primary areas of investigation include Internal medicine, Gastroenterology, Chemotherapy, Hepatectomy and Cumulative incidence.
As part of his studies on Internal medicine, Michael I. D’Angelica often connects relevant subjects like Oncology.
The Gastroenterology study combines topics in areas such as Liver surgery, Primary tumor and Hazard ratio.
His Chemotherapy research incorporates elements of Portal hypertension and Hepatic arterial infusion.
The concepts of his Hepatectomy study are interwoven with issues in Interventional radiology, Bevacizumab, Prognostic variable and Mutant.
His Colorectal cancer study combines topics in areas such as Survival analysis, Proportional hazards model and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
